Commercial
  
  
  
  
  
  
  
  
  
  
  
MPattachmentdataPub
  
dd7d4df3-15f5-4b1a-8cd1-1ddfcc747c8e.aspx
  
3196Teprotumumab(Tepezza™)08.00.41Pharmacy (08)08.00.4108.00.41Teprotumumab (Tepezza™)Teprotumumab (Tepezza™)4/23/2021 9:00 AMdd7d4df3-15f5-4b1a-8cd1-1ddfcc747c8e
5/24/2021
936e7f75-1db7-4e22-8b37-899c41a552f9.aspx
  
3098LipectomyandLiposuction11.08.03kSurgery (11)11.08.03k11.08.03Lipectomy and LiposuctionLipectomy and Liposuction3/30/2021 2:00 PM936e7f75-1db7-4e22-8b37-899c41a552f9
6/28/2021
57790c50-3680-4113-adef-aae8c2d1ae05.aspx
  
3100SpinalDiscectomy(AmerihealthAdministrators)11.14.29hSurgery (11)11.14.29h11.14.29Spinal Discectomy (Amerihealth Administrators)Spinal Discectomy (Amerihealth Administrators)4/1/2021 11:00 AM57790c50-3680-4113-adef-aae8c2d1ae05
7/1/2021
d95b9cdc-8234-4fa7-a9d2-8404f2b5af69.aspx
  
3127TelemedicineServices(AmeriHealthPennsylvania)00.10.41hAdministrative (00)00.10.41h00.10.41Telemedicine Services (AmeriHealth Pennsylvania)Telemedicine Services (AmeriHealth Pennsylvania)4/1/2021 5:00 PMd95b9cdc-8234-4fa7-a9d2-8404f2b5af69
7/1/2021
5d8302e8-d4d7-459c-9a68-73fc07fcce23.aspx
  
3144RoutineCostsAssociatedwithQualifyingClinicalTrials07.00.20gMedicine (07)07.00.20g07.00.20Routine Costs Associated with Qualifying Clinical TrialsRoutine Costs Associated with Qualifying Clinical Trials4/6/2021 2:00 PM5d8302e8-d4d7-459c-9a68-73fc07fcce23
7/5/2021
5e309e5e-4c1d-4c55-94ef-ed921b2617fe.aspx
  
3166Experimental/InvestigationalServices12.01.01baMiscellaneous (12)12.01.01ba12.01.01Experimental/Investigational ServicesExperimental/Investigational Services4/12/2021 12:00 PM5e309e5e-4c1d-4c55-94ef-ed921b2617fe
{"3167": {"Id":3167,"MPAttachmentLetter":"C","Title":"Experimental/Investigational services with a specific Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System (HCPCS) Code, that are reported for other services.","MPPolicyAttachmentInternalSourceId":5375,"PolicyAttachmentPageName":"538b43ce-3603-4657-a4b7-839ec40080f3"},"3168": {"Id":3168,"MPAttachmentLetter":"B","Title":"Experimental/Investigational Services without a Specific Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System (HCPCS) Code.","MPPolicyAttachmentInternalSourceId":5376,"PolicyAttachmentPageName":"a26d3279-d643-4912-bd2b-d0921387184a"},"3169": {"Id":3169,"MPAttachmentLetter":"A","Title":"Experimental/Investigational Services Represented by a Specific Current Procedural Terminology (CPT) or Healthcare Common Procedure Coding System (HCPCS) Code.","MPPolicyAttachmentInternalSourceId":5377,"PolicyAttachmentPageName":"573def63-357e-49fe-80d7-5da0a2d1b90a"},}
7/12/2021
ef00cf3e-fb4b-47ff-b4e0-3e6921d8b192.aspx
  
3232Inebilizumab-cdon(Uplizna)08.01.68bPharmacy (08)08.01.68b08.01.68Inebilizumab-cdon (Uplizna)Inebilizumab-cdon (Uplizna)5/11/2021 1:00 PMef00cf3e-fb4b-47ff-b4e0-3e6921d8b192
8/9/2021